Blood Lead Levels of Children Using Traditional Indian Medicine and Cosmetics: A Feasibility Study.

Ayurvedic medicine blood lead levels children kohl pediatric traditional medicine

Journal

Global advances in health and medicine
ISSN: 2164-957X
Titre abrégé: Glob Adv Health Med
Pays: United States
ID NLM: 101584936

Informations de publication

Date de publication:
2019
Historique:
received: 30 11 2018
revised: 12 06 2019
accepted: 09 07 2019
entrez: 7 9 2019
pubmed: 7 9 2019
medline: 7 9 2019
Statut: epublish

Résumé

Traditional Indian cosmetics and Ayurvedic medicines may contain lead. Previous studies have shown a relationship between eye cosmetic use (kohl) in children and elevated blood lead levels (BLLs) > 10 µg/dL. However, an association between Ayurvedic use and elevated BLLs in children is unknown and understudied. We assessed the feasibility of collecting BLLs in children attending Ayurvedic outpatient settings in India. Our pilot study took place over 3 days in the summer of 2010 at a large public Ayurveda hospital and a small pediatric clinic in southern India. Using a trained interpreter, we administered a standardized questionnaire in Malayalam, assessing sociodemographics, Ayurvedic medicine use, kohl use, and other potential risk factors for lead exposure, to parents of pediatric outpatients. We also analyzed BLLs using a portable lead analyzer. The study enrolled 29 children (mean age, 3.8 years). The mean BLL was 6.7 µg/dL (SD = 3.5; range, 3.5-20.2). Seventy-two percent of the children used Ayurvedic medicine in the past 2 years and 55% reported kohl use. Mean BLL of Ayurvedic users and nonusers was 6.2 µg/dL and 8.5 µg/dL, respectively ( It is feasible to collect BLLs in pediatric Ayurvedic outpatient clinics in southern India. Collaborative relationships with community members and hospital staff were essential. Further research is needed to investigate Ayurveda and kohl use as risk factors for elevated lead burden among Indian children.

Sections du résumé

BACKGROUND BACKGROUND
Traditional Indian cosmetics and Ayurvedic medicines may contain lead. Previous studies have shown a relationship between eye cosmetic use (kohl) in children and elevated blood lead levels (BLLs) > 10 µg/dL. However, an association between Ayurvedic use and elevated BLLs in children is unknown and understudied.
METHODS METHODS
We assessed the feasibility of collecting BLLs in children attending Ayurvedic outpatient settings in India. Our pilot study took place over 3 days in the summer of 2010 at a large public Ayurveda hospital and a small pediatric clinic in southern India. Using a trained interpreter, we administered a standardized questionnaire in Malayalam, assessing sociodemographics, Ayurvedic medicine use, kohl use, and other potential risk factors for lead exposure, to parents of pediatric outpatients. We also analyzed BLLs using a portable lead analyzer.
RESULTS RESULTS
The study enrolled 29 children (mean age, 3.8 years). The mean BLL was 6.7 µg/dL (SD = 3.5; range, 3.5-20.2). Seventy-two percent of the children used Ayurvedic medicine in the past 2 years and 55% reported kohl use. Mean BLL of Ayurvedic users and nonusers was 6.2 µg/dL and 8.5 µg/dL, respectively (
CONCLUSIONS CONCLUSIONS
It is feasible to collect BLLs in pediatric Ayurvedic outpatient clinics in southern India. Collaborative relationships with community members and hospital staff were essential. Further research is needed to investigate Ayurveda and kohl use as risk factors for elevated lead burden among Indian children.

Identifiants

pubmed: 31489260
doi: 10.1177/2164956119870988
pii: 10.1177_2164956119870988
pmc: PMC6709437
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2164956119870988

Références

Neurotoxicol Teratol. 2001 Nov-Dec;23(6):511-8
pubmed: 11792521
Eur J Clin Pharmacol. 2002 Feb;57(12):891-6
pubmed: 11936709
Saudi Med J. 2002 May;23(5):591-3
pubmed: 12070589
Drug Saf. 2002;25(14):1005-19
pubmed: 12408732
Neurotox Res. 2003;5(3):221-36
pubmed: 12835126
Pediatrics. 1992 Dec;90(6):855-61
pubmed: 1437425
Int J Environ Health Res. 2004 Feb;14(1):83-91
pubmed: 14660121
Isr J Med Sci. 1992 Jul;28(7):417-21
pubmed: 1506164
JAMA. 2004 Dec 15;292(23):2868-73
pubmed: 15598918
Curr Opin Pediatr. 2008 Apr;20(2):172-7
pubmed: 18332714
Pediatrics. 2010 Apr;125(4):e828-35
pubmed: 20231190
Trop Med Health. 2011 Dec;39(4):127-32
pubmed: 22438702
Clin Pediatr (Phila). 2015 Jun;54(7):690-2
pubmed: 25305259
Occup Med (Lond). 2015 Jul;65(5):348-56
pubmed: 26187801
Can Dis Wkly Rep. 1989 Sep 2;15(35):177-9
pubmed: 2791074
Public Health. 1979 Sep;93(5):274-84
pubmed: 515330
Int Ophthalmol. 1995;19(2):83-8
pubmed: 8586501

Auteurs

Julia Keosaian (J)

Department of Family Medicine, Boston Medical Center, Boston, Massachusetts.
Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, Massachusetts.

Thuppil Venkatesh (T)

National Referral Centre for Lead Poisoning, St. John's Medical College, Bangalore, India.

Salvatore D'Amico (S)

Department of Family Medicine, Boston Medical Center, Boston, Massachusetts.

Paula Gardiner (P)

Department of Family Medicine, Boston Medical Center, Boston, Massachusetts.

Robert Saper (R)

Department of Family Medicine, Boston Medical Center, Boston, Massachusetts.

Classifications MeSH